Metraipolis › archive › dc_a277e3542e01
Advances in β-Thalassemia Gene Therapy: CRISPR/Cas Systems and Delivery Innovations — Europe PMC PMID:41148810
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41148810
- DOI
- 10.3390/cells14201595
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T08:51:00.677Z
- SHA-256 of the archived text
272a4f6a2dcbb9842d8c68e8d7281d50bda631b453ab7b7dcae1e3518fc0677b- Stable URL of this page
https://metraipolis.com/documento/dc_a277e3542e01
How to cite
Advances in β-Thalassemia Gene Therapy: CRISPR/Cas Systems and Delivery Innovations — Europe PMC PMID:41148810 — Europe PMC (en), https://europepmc.org/article/MED/41148810 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a277e3542e01 (Metraipolis archive dc_a277e3542e01, sha256 272a4f6a2dcbb9842d8c68e8d7281d50bda631b453ab7b7dcae1e3518fc0677b)
BibTeX
@misc{dca277e3542e01,
title = {Advances in β-Thalassemia Gene Therapy: CRISPR/Cas Systems and Delivery Innovations — Europe PMC PMID:41148810},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41148810},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a277e3542e01; sha256 272a4f6a2dcbb9842d8c68e8d7281d50bda631b453ab7b7dcae1e3518fc0677b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41148810. Agents can read the archived copy with the MCP tool read_document.